• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

With Bronchiolitis Season in Full Swing, New Insights into Factors Affecting Severity

Article

Although bronchiolitis is commonly seen in very young children, the infection can be dangerous and even fatal for some infants. Here, new thoughts on risk factors that may determine which babies get very sick.

A Quick Quiz on Bronchiolitis

Click here for Question 2

Click here for Question 3

Click here for article

Although it is one of the most common lower respiratory tract infections of very young children, bronchiolitis can be dangerous and even fatal for some infants. 

There are different, perhaps previously unappreciated, factors that can make otherwise healthy children sick enough to require intensive care. The authors of a recently published study of risk factors that predispose to severe disease found that compared with infants who weather the bronchiolitis storm well, those who become seriously ill share certain distinguishing characteristics:

• They are smaller, younger (<3 months), and more likely to have been delivered by cesarean section. The younger the infant, the more likely he or she is to require admission to the pediatric ICU.
• Their hemoglobin, sodium, and lymphocyte counts are lower, and gamma-glutamyl transpeptidase (GGT) levels are higher.

• Their chest films show more pulmonary consolidation and/or atelectasis. Infants with the most consolidation/atelectasis have the highest serum levels of C-reactive protein.

Patient selection
Papoff and colleagues1 followed 310 infants younger than 12 months of age who were having a first episode of bronchiolitis. Infants were selected over 5 epidemic seasons so that an adequate sample size could be collected while minimizing the effect of changing standards of care. Unlike other studies of bronchiolitis, all infants were otherwise healthy; the investigators excluded those who were premature, extremely young (younger than 37 weeks) or underweight (<2000 g at birth), or compromised by congenital heart disease or immunodeficiency. Infants were sorted into 4 groups based on severity of illness--ranging from needing no oxygen or fluids, to requiring fluids and/or oxygen or mechanical ventilation/noninvasive respiratory support. Epidemiologic, clinical, demographic, radiologic, and laboratory data were evaluated with respect to these groupings.

The investigators found that epidemiologic factors such as maternal smoking, family incidence of atopy, and breastfeeding, had no significant bearing on severity of bronchiolitis. This effect could have been related to the general good health of the children studied.

The investigators also performed viral analysis on nasal washings from each child. There were a variety of causative viruses, but respiratory syncytial virus (RSV) was most common. Children most susceptible to RSV were those with pulmonary consolidation/atelectasis or high levels of C-reactive protein.

Most of the infants in the study were admitted to intensive care right from admission, suggesting that in healthy infants who are carried to term, severe bronchiolitis probably develops too early to be predicted or prevented.

Reference

Papoff P, Moretti C, Cangiano G, et al. Incidence and predisposing factors for severe disease in previously healthy term infants experiencing their first episode of bronchiolitis. Acta Paediatr. 2011;100:e17-e23.

 

Related Videos
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief, Contemporary Pediatrics, professor of pediatrics, Feinberg School of Medicine, Northwestern University, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital of Chicago
Samir Gautam, MD, PhD | Image Credit: Yale School of Medicine
John Bradley, MD
Pfizer's infant RSV vaccine receives FDA Advisory Committee's support | Image Credit: Dr_Microbe - Image Credit: Dr_Microbe
Related Content
© 2024 MJH Life Sciences

All rights reserved.